Akso Health Group cash flow statement

In fiscal 2026, Akso Health Group's operations generated −$12.8m of cash; it spent $1,638 on capital projects, leaving free cash flow of −$12.8m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Akso Health Group: cash flow statement, annual
Fiscal year	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Cash from operations	8	88	−2	−58	10	−9	−3	1	1	−13
Depreciation and amortisation	0	0	0	0	0	0	—	—	2	2
Stock-based pay	0	2	7	0	0	0	—	—	—	—
Capital spending	0	0	0	0	—	0	—	—	0	0
Free cash flow	8	87	−2	−58	—	−9	—	—	1	−13
Free cash flow after stock pay	8	85	−8	−59	—	−9	—	—	—	—
Dividends paid	—	—	20	—	—	—	—	—	—	—
Share buybacks	—	—	1	3	—	—	—	—	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AHG vs AMS AHG vs CCEL AHG vs HAO

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Akso Health Group's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Akso Health Group.